Boris Draznin – författare

Being overweight dramatically increases the risk of diabetes. Research shows that only a permanent lifestyle change can take weight off and keep it off, and thus prevent diabetes in those who might otherwise suffer from this debilitating and dreaded disease. Living with Diabetes: Dr. Draznin's Plan for Better Health offers a truly practical, and proven, approach to lifestyle change that will stay with you long term: a simple way to lose weight and keep it off, and to prevent or manage diabetes. Filled with amusing anecdotes and down-to-earth advice that make the book both fun to read and easy to follow, Living with Diabetes offers a dramatically different method of weight loss and management based on the refreshingly simple concepts of the Draznin Mile and the Draznin Calorie, two unique strategies that can help you lose weight quickly and safely. For this fully revised and updated edition, Dr. Draznin has incorporated many recent research findings in nutrition and weight managementadvances in our understanding of weight regulation, energy expenditure, and how Americans can learn to change the way they eat. An evaluation of fad diets such as South Beach, Atkins, and the Zone has been added, while statistics on obesity and health have been fully updated. Dr. Draznin also weighs the risks and benefits of surgical approaches such as gastric bypass, and discusses the newest methods of treating diabetes and pre-diabetes.Drawing on his successful treatment of thousands of overweight and diabetic patients over 30 years of medical practice, Dr. Boris Draznin offers a practical and easy-to-follow plan that will appeal to those who have or are at risk for diabetes, as well as anyone interested in losing weight in a healthy and sustainable manner.

The discipline of Endocrinology encompasses diabetes and obesity, two of the most common and pressing health care concerns today. The Oxford American Handbook of Endocrinology & Diabetes concisely reviews the entire discipline, providing a wealth of daily help for students and residents managing patients with diabetes and obesity as well as reproductive and neuroendocrine disorders, pediatric endocrinology, and problems of the thyroid, pituitary, and adrenal glands. Key topics such as genetics, therapeutic agents, and results of major clinical trials are included, all in a compact and easily-navigable package.

These comprehensive yet concise collections of articles by world experts survey the latest findings on the molecular biology of diabetes and insulin action and synthesize a coherent understanding of the subject. Topics include the etiology of type I and type II diabetes, molecular and cellular aspects of insulin action, and the mechanism of the insulin-stimulated glucose uptake.

These comprehensive yet concise collections of articles by world experts survey the latest findings on the molecular biology of diabetes and insulin action and synthesize a coherent understanding of the subject.

An unprecedented compilation of state-of-the-art advances in clinical research on diabetes and obesity by premier clinical scientists around the world.

An unprecedented compilation of state-of-the-art advances in clinical research by premier clinical scientists around the world. This volume discusses the methods of clinical research and the interpretation of their results in studies of normal individuals, obese subjects, and patients with diabetes mellitus. Along the way, the authoritative contributors writing here illuminate how changes in the hormone action and substrate metabolism of healthy humans may lead to obesity and noninsulin-dependent diabetes mellitus.

In a rapidly evolving and extremely important area of medical science, it is often difficult for the student, teacher, and researcher to keep abreast of all the important advances. The purpose of Molecular Biology ofDiabetes, Parts I and II is to bring to these individuals the latest knowledge of diabetes-related research in a comprehensive, yet concise manner. To this end, we have assembled chapters, written by most of the world's experts in the field, that we believe compre­ hensively survey and synthesize a coherent understanding of the subject. Studies of the etiology of type I and type II diabetes are extremely exciting and essential, since we hope to one day prevent the disease using gene therapy. These aspects are covered in Molecular Biology of Diabetes: I. Autoimmunity and Genetics; Insulin Synthesis and Secretion. In type II diabetes, an abnormality in pancreatic secretion exists concomitantly with peripheral insulin resistance. This abnor­ mality of insulin secretion is believed to be related to a defect(s) in glucose sensing. Uncoupling of glucose sensing from insulin secre­ tion may be the crucial step in the pathogenesis of noninsulin-depen­ dent diabetes. In this volume, we have invited authors to describe their studies on all known factors affecting ~-cell function, including autoimmunity and genetics of diabetes, as well as molecular mecha­ nisms of insulin synthesis and secretion. In the last few years, the most rapidly advancing area of research in diabetes has been, in fact, related to insulin action.

The "case study" approach is one of the most used and most effective formats to present medical information and is the foundation for developing evidence-based treatment protocols. Compiled and edited by one of the world's best known clinical endocrinologists, Boris Draznin, MD, PhD, Diabetes Case Studies offers more than 100 actual cases from leading diabetologists, outlining both typical and unusual diabetes cases. Each study will illustrate real life dilemmas with a discussion as to how the diagnostic and therapeutic approaches were selected and implemented, through a thorough, yet succinct, presentation of the problems, the diagnoses, treatment protocols, and results. Readers will have practical information to use when treating their diabetic patients.

As the number of patients with diabetes increases annually, it is not surprising that the number of patients with diabetes who are admitted to the hospital also increases. Once in the hospital, patients with diabetes or hyperglycemia may be admitted to the Intensive Care Unit, require urgent or elective surgery, enteral or parenteral nutrition, intravenous insulin infusion, or therapies that significantly impact glycemic control (e.g., steroids). Because many clinical outcomes are influenced by the degree of glycemic control, knowledge of the best practices in inpatient diabetes management is extremely important. The field of inpatient management of diabetes and hyperglycemia has grown substantially in the last several years. This body of knowledge is summarized in this book, so it can reach the audience of hospitalists, endocrinologists, nurses and other team members who take care of hospitalized patients with diabetes and hyperglycemia.

These comprehensive yet concise collections of articles by world experts survey the latest findings on the molecular biology of diabetes and insulin action and synthesize a coherent understanding of the subject.

An unprecedented compilation of state-of-the-art advances in clinical research on diabetes and obesity by premier clinical scientists around the world.

An unprecedented compilation of state-of-the-art advances in clinical research by premier clinical scientists around the world. This volume discusses the methods of clinical research and the interpretation of their results in studies of normal individuals, obese subjects, and patients with diabetes mellitus. Along the way, the authoritative contributors writing here illuminate how changes in the hormone action and substrate metabolism of healthy humans may lead to obesity and noninsulin-dependent diabetes mellitus.